|
Volumn 314, Issue 5802, 2006, Pages 1064-1065
|
Chinese drug research. Novartis invests $100 million in Shanghai.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADMINISTRATIVE PERSONNEL;
ARTICLE;
CHINA;
DRUG INDUSTRY;
ECONOMICS;
EDUCATION;
INTERNATIONAL COOPERATION;
INVESTMENT;
MEDICAL RESEARCH;
ORGANIZATION AND MANAGEMENT;
SWITZERLAND;
ADMINISTRATIVE PERSONNEL;
BIOMEDICAL RESEARCH;
CHINA;
DRUG INDUSTRY;
INTERNATIONAL AGENCIES;
INVESTMENTS;
SWITZERLAND;
MLCS;
MLOWN;
|
EID: 39049186999
PISSN: None
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.314.5802.1064b Document Type: Article |
Times cited : (3)
|
References (0)
|